Discovering Venom-Derived Drug Candidates Using Differential Gene Expression

Area of Science:

• Biotechnology
• Bioinformatics
• Pharmacology

Background:

• Venoms are complex natural toxins with potential therapeutic applications.
• Discovering new therapeutic activities from venoms is challenging due to a lack of systematic computational approaches.
• Existing methods for venom analysis are limited in scope and throughput.

Purpose of the Study:

• To design and validate VenomSeq, a novel computational platform for systematically identifying therapeutic associations of venoms.
• To leverage high-throughput transcriptomics and differential gene expression analysis for venom-drug/disease association.
• To generate new therapeutic hypotheses by integrating diverse biological data.

Main Methods:

• Developed VenomSeq, a platform integrating transcriptomics and gene expression analysis.
• Applied VenomSeq to analyze crude venoms from 25 animal species and 9 purified teretoxin peptides.
• Integrated public differential expression data, disease-associated regulatory networks, and known venom activities.

Main Results:

• Successfully validated the VenomSeq platform architecture.
• Identified putative associations between venoms and various drugs/diseases.
• Generated multiple novel therapeutic hypotheses linking venoms to human diseases.

Conclusions:

• VenomSeq offers a powerful new tool for systematic discovery of venom-derived therapeutics.
• The platform provides preliminary evidence supporting novel venom-disease associations.
• This work expands the potential of venoms in drug discovery and human disease treatment.